Background: Patients with chronic kidney disease (CKD) have a high prevalence of sleep disorders. The association between sleep duration and self-reported CKD was examined in a population of Americans who participated in a national survey over a 3-year period. Study Design: A cross-sectional study using survey data from the National Health Interview Survey (NHIS) from the year 2004-2006 was carried out. A retrospective examination of data from a community-based survey of 128,486 noninstitutionalized US civilian residents over the age of 18 years was conducted. Self-reported CKD was defined as having ‘weak or failing kidneys'. The sleep duration was defined by a self-reported estimate of habitual sleep duration. Results: The prevalence of participants self-reporting kidney disease was higher in those with short (≤6 h per night) and long (≥8 h per night) sleep durations when compared to those sleeping 7 h per night. Self-reported information about sleep, demographic information, and information on comorbidities were assessed using standardized validated questionnaires which reported no kidney disease. A multivariate logistic regression analysis showed increased odds of self-reported kidney disease in study participants with both short and long sleep durations compared to healthy sleepers (sleeping >7-8 h per night). Observational data do not permit examination of causality, although possible confounders in observations of interest can be adjusted. Conclusion: Among Americans surveyed in the NHIS (2004-2006), those with short or long sleep duration had higher odds of reporting that they had CKD. i 2014 S. Karger AG, Basel

Keywords:
Chronic kidney disease, Sleep duration, Race/ethnicity
1.
Gangwisch JE, Heymsfield SB, Boden-Albala B, et al: Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension 2006;47:833-839.
2.
Buxton OM, Marcelli E: Short and long sleep are positively associated with obesity, diabetes, hypertension, and cardiovascular disease among adults in the United States. Soc Sci Med 2010;71:1027-1036.
3.
Gottlieb DJ, Punjabi NM, Newman AB, et al: Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med 2005;165:863-867.
4.
Stranges S, Cappuccio FP, Kandala NB, et al: Cross-sectional versus prospective associations of sleep duration with changes in relative weight and body fat distribution: the Whitehall II Study. Am J Epidemiol 2008;167:321-329.
5.
Sabanayagam C, Shankar A: Sleep duration and cardiovascular disease: results from the National Health Interview Survey. Sleep 2010;33:1037-1042.
6.
Cappuccio FP, D'Elia L, Strazzullo P, Miller MA: Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep 2010;33:585-592.
7.
Coresh J, Selvin E, Stevens LA, et al: Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-2047.
8.
Pierratos A, Hanly PJ: Sleep disorders over the full range of chronic kidney disease. Blood Purif 2011;31:146-150.
9.
Unruh ML, Levey AS, D'Ambrosio C, Fink NE, Powe NR, Meyer KB: Restless legs symptoms among incident dialysis patients: association with lower quality of life and shorter survival. Am J Kidney Dis 2004;43:900-909.
10.
Gigli GL, Adorati M, Dolso P, et al. Restless legs syndrome in end-stage renal disease. Sleep Med 2004;5:309-315.
11.
Elder SJ, Pisoni RL, Akizawa T, et al: Sleep quality predicts quality of life and mortality risk in haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2008;23:998-1004.
12.
Unruh ML, Sanders MH, Redline S, et al: Subjective and objective sleep quality in patients on conventional thrice-weekly hemodialysis: comparison with matched controls from the sleep heart health study. Am J Kidney Dis 2008;52:305-313.
13.
Sim JJ, Rasgon SA, Kujubu DA, et al: Sleep apnea in early and advanced chronic kidney disease: Kaiser Permanente Southern California cohort. Chest 2009;135:710-716.
14.
Plantinga L, Lee K, Inker LA, et al: Association of sleep-related problems with CKD in the United States, 2005-2008. Am J Kidney Dis 2011;58:554-564.
15.
Yamamoto R, Nagasawa Y, Iwatani H, et al: Self-reported sleep duration and prediction of proteinuria: a retrospective cohort study. Am J Kidney Dis 2012;59:343-355.
16.
Design and estimation for the National Health Interview Survey, 1995-2004. Vital Health Stat 2 2000:1-31.
17.
Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR: Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 2002;59:131-136.
18.
Kessler RC, Barker PR, Colpe LJ, et al: Screening for serious mental illness in the general population. Arch Gen Psychiatry 2003;60:184-189.
19.
Kutner NG, Bliwise DL, Zhang R: Linking race and well-being within a biopsychosocial framework: variation in subjective sleep quality in two racially diverse older adult samples. J Health Soc Behav 2004;45:99-113.
20.
Charloux A Gronfier C, Chapotot F, Ehrhart J, Piquard F, Brandenberger G: Sleep deprivation blunts the night time increase in aldosterone release in humans. J Sleep Res 2001;10:27-33.
21.
Kamperis K, Hagstroem S, Radvanska E, Rittig S, Djurhuus JC: Excess diuresis and natriuresis during acute sleep deprivation in healthy adults. Am J Physiol Renal Physiol 2010;299:F404-F411.
22.
Perry JC, Bergamaschi CT, Campos RR, Andersen ML, Montano N, Casarini DE, Tufik S: Sympathetic and angiotensinergic responses mediated by paradoxical sleep loss in rats. J Renin Angiotensin Aldosterone Syst 2011;12:146-152.
23.
Martino TA, Oudit GY, Herzenberg AM, Tata N, Koletar MM, Kabir GM, Belsham DD, Backx PH, Ralph MR, Sole MJ: Circadian rhythm disorganization produces profound cardiovascular and renal disease in hamsters. Am J Physiol Regul Integr Comp Physiol 2008;294:R1675-R1683.
24.
Vgontzas AN, Zoumakis E, Bixler EO, Lin HM, Follett H, Kales A, Chrousos GP: Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab 2004;89:2119-2126.
25.
Meier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, Dinges DF, Mullington JM: Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 2004;43:678-683.
26.
van Leeuwen WM, Lehto M, Karisola P, Lindholm H, Luukkonen R, Sallinen M, Harma M, Porkka-Heiskanen T, Alenius H: Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRP. PLoS One 2009;4:e4589.
27.
Williams CJ, Hu FB, Patel SR, Mantzoros CS: Sleep duration and snoring in relation to biomarkers of cardiovascular disease risk among women with type 2 diabetes. Diabetes Care 2007;30:1233-1240.
28.
Patel SR, Zhu X, Storfer-Isser A, Mehra R, Jenny NS, Tracy R, Redline S: Sleep duration and biomarkers of inflammation. Sleep 2009;32:200-204.
29.
Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR, Vinh A, Weyand CM: Inflammation, immunity, and hypertension. Hypertension 2011;57:132-140.
30.
Lefsky JM, Glass CK: Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010;72:219-246.
31.
Weil BR, Mestek ML, Westby CM, Van Guilder GP, Greiner JJ, Stauffer BL, DeSouza CA: Short sleep duration is associated with enhanced endothelin-1 vasoconstrictor tone. Can J Physiol Pharmacol 2010;88:777-781.
32.
Viljoen M, Steyn ME, van Rensburg BW, Reinach SG: Melatonin in chronic renal failure. Nephron 1992;60:138-143.
33.
Vaziri ND, Oveisi F, Reyes GA, Zhou XJ: Dysregulation of melatonin metabolism in chronic renal insufficiency: role of erythropoietin-deficiency anemia. Kidney Int 1996;50:653-656.
34.
Hanly PJ, Pierratos A: Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med 2001;344:102-107.
35.
Beecroft JM, Zaltzman J, Prasad R, Meliton G, Hanly PJ: Impact of kidney transplantation on sleep apnoea in patients with end-stage renal disease. Nephrol Dial Transplant 2007;22:3028-3033.
36.
Jurado-G%mez B, Martin-Malo A, Rodriguez-Benot A, MuAoz-Cabrera L, Cosano Povedano A, Aljama P: Kidney transplantation improves sleep-related breathing in hemodialysis patients. Blood Purif 2008;26:485-490.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.